AgaMatrix is a technology company that has successfully commercialized over 10 FDA-cleared medical diagnostics products in the glucose/ diabetes monitoring space. Founded in 2001 by scientists from MIT and Cambridge, AgaMatrix has grown to 130 employees worldwide, with offices in the US, UK, South Korea and China, and a stellar management team and investors that include founders/ executives from MediSense and Inverness Medical (two leaders in the Blood Glucose industry). Together with manufacturing partners in South Korea and newly acquired factories in China, there are more 500 people supporting the production of AgaMatrix products. AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company’s products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. WaveSense Dynamic Electrochemistry is a novel DSP-based (Digital Signal Processing) method of real-time feedback algorithms to control the accuracy of electrochemical sensors. To date, AgaMatrix attracted many high-profile commercial partners. Sanofi-Aventis, one of the largest pharmaceutical companies in the world, and the largest manufacturer of insulin, has selected AgaMatrix as its Glucose Meter partner and is commercializing the world’s first glucose meter connected to the IPhone. In the US, AgaMatrix has partnered with the largest mail-order MediCare provider, Medco, to supply private-labeled glucose meters (under its ‘Liberty’ brand). Additionally, AgaMatrix has partnered with Perrigo, the US’s largest store-brand supplier/ manufacturer of over-the-counter medical products. AgaMatrix’s reputation for high quality and innovation has allowed it to grow into a multi-national company with top tier partners.